Tumor biology and cancer research
Gain expert insights and discover the latest technological advancements in tumor biology and cancer research, keeping you at the forefront of innovation in the fight against cancer.
Cancer is a puzzle scientists have been trying to solve for decades. Tumors are not just masses of cells, they are complex ecosystems, constantly evolving and interacting with the body around them. Understanding how they grow, spread, and respond to treatments is at the heart of cancer research today. From lab-grown 3D tumor models to cutting-edge multiomics and immunotherapy studies, researchers are uncovering new ways to detect, treat, and even prevent cancer. In this feature, we explore the latest discoveries in tumor biology and show how science is turning knowledge into action against one of medicine’s toughest challenges.
The tumor microenvironment: A complex ecosystem
This new whitepaper explores how the tumor microenvironment drives cancer progression, immune evasion, and treatment resistance, offering actionable insights for researchers, drug developers, and oncologists. Discover how advanced proteomics can identify key biomarkers and guide the development of personalized therapies.
Download whitepaper
Imaging with Jackson ImmunoResearch Secondary Antibodies
Immunostaining is widely used to study biological processes in situ, especially in cancer and neuroscience. As experiments become more complex, precise detection tools are essential. This article explores how Jackson ImmunoResearch cross-adsorbed and NEW Anti-GFP antibodies can enhance accuracy and specificity in advanced research.
Read article
Understanding the impact of EGFR signalling in NSCLC
Explore EGFR-mutant NSCLC through key statistics, high-incidence demographics, and a timeline of targeted therapy development. This infographic illustrates the EGFR signalling pathway and showcases advanced technologies (such as patient-derived xenografts, spatial imaging, and liquid biopsies) driving precision medicine and the discovery of new EGFR-targeted treatments.
Download poster
Teaching AI to see: How the next era of digital pathology is being driven by curated biospecimen data
In this article, Daryl Waggott of BioIVT explores how linking whole-slide images with rich clinical and molecular context is enabling smarter, biologically informed algorithms, moving beyond pattern recognition to true tissue intelligence and advancing cancer research.
Read article
Elephas Live™ Method: A sequential approach to tackle tissue scarcity and heterogeneity in live tumor fragments
This whitepaper presents a rigorous evaluation of the Elephas Live™ Method, a sequential ex vivo treatment approach designed to overcome challenges like tissue scarcity and intratumor heterogeneity in core needle biopsy–derived live tumor fragments.
Download whitepaper
Generation and characterization of diverse modality ADCs
Discover ChemPartner's comprehensive development and screening services for clients developing multispecifics or dual-payload ADCs. Learn how their services help clients create translatable therapeutics that enhance tumor targeting and overcome resistance.
Download poster
In vivo imaging with GFP: From blue squeezates to green mice
In this application note, Analytik Jena showcases how the UVP iBox Studio enables high-sensitivity, non-invasive in vivo GFP imaging in orthotopic mouse models, providing researchers with detailed, real-time visualization of tumor growth and fluorescent protein expression.
Download application note
How data and AI are accelerating cancer clinical trials
Phesi founder, Dr. Gen Li, explains how patient-centric data science and AI are transforming cancer clinical trials. Through the Trial Accelerator™ platform, Phesi leverages real-world data and predictive analytics to improve trial design, reduce patient burden, and accelerate the development of life-saving therapies globally.
Read article
Mapping human tissues with 6-base sequencing
biomodal showcases how 6-base sequencing, using duet evoC and their new analysis software modality XPLR, can simultaneously profile 5mC and 5hmC across tissues, revealing distinct epigenetic signatures and regulatory pathways that define tissue identity and advance gene regulation research.
Download poster
